These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8198464)

  • 21. Pathophysiology and treatment of Wilson's disease.
    Tankanow RM
    Clin Pharm; 1991 Nov; 10(11):839-49. PubMed ID: 1794220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Wilson's disease : What has been confirmed in diagnostic and therapy?].
    Pfister ED
    Internist (Berl); 2017 Dec; 58(12):1233-1241. PubMed ID: 29098318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Wilson's disease].
    Kovacević I; Zekan M
    Acta Med Croatica; 2003; 57(3):227-35. PubMed ID: 14582469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease.
    Brewer GJ
    Exp Biol Med (Maywood); 2001 Jul; 226(7):665-73. PubMed ID: 11444102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early neurological worsening in patients with Wilson's disease.
    Litwin T; Dzieżyc K; Karliński M; Chabik G; Czepiel W; Członkowska A
    J Neurol Sci; 2015 Aug; 355(1-2):162-7. PubMed ID: 26071888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years.
    Brewer GJ; Dick RD; Johnson VD; Fink JK; Kluin KJ; Daniels S
    J Lab Clin Med; 2001 Mar; 137(3):191-8. PubMed ID: 11241029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Status epilepticus in Wilson's disease.
    Pestana Knight EM; Gilman S; Selwa L
    Epileptic Disord; 2009 Jun; 11(2):138-43. PubMed ID: 19473947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy.
    Brewer GJ; Terry CA; Aisen AM; Hill GM
    Arch Neurol; 1987 May; 44(5):490-3. PubMed ID: 3579660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of the neurologic manifestations of Wilson's disease.
    Scheinberg IH; Sternlieb I
    Arch Neurol; 1995 Apr; 52(4):339-40. PubMed ID: 7710368
    [No Abstract]   [Full Text] [Related]  

  • 31. Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series.
    De Fabregues O; Viñas J; Palasí A; Quintana M; Cardona I; Auger C; Vargas V
    Brain Behav; 2020 May; 10(5):e01596. PubMed ID: 32202078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wilson's disease. Psychiatric manifestations may be the clinical presentation.
    Jackson GH; Meyer A; Lippmann S
    Postgrad Med; 1994 Jun; 95(8):135-8. PubMed ID: 8202418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of copper-lowering therapy with tetrathiomolybdate in medicine.
    Brewer GJ
    Expert Opin Investig Drugs; 2009 Jan; 18(1):89-97. PubMed ID: 19053885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
    Hoogenraad TU
    Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
    Merle U; Schaefer M; Ferenci P; Stremmel W
    Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
    Brewer GJ; Dick RD; Yuzbasiyan-Gurkan V; Johnson V; Wang Y
    J Lab Clin Med; 1994 Jun; 123(6):849-58. PubMed ID: 8201263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trientine-induced neurological deterioration in a patient with Wilson's disease.
    Kim B; Chung SJ; Shin HW
    J Clin Neurosci; 2013 Apr; 20(4):606-8. PubMed ID: 23274038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse reaction after tetrathiomolybdate treatment for Wilson's disease: a case report.
    Medici V; Trevisan CP; Bigotto MA; D'Incà R; Martines D; Dal Pont E; Sturniolo GC
    Mov Disord; 2006 Nov; 21(11):2030-2. PubMed ID: 16991142
    [No Abstract]   [Full Text] [Related]  

  • 39. Anticopper efficacy of captopril and sodium dimercaptosulphonate in patients with Wilson's disease.
    Wang XP; Yang RM; Ren MS; Sun BM
    Funct Neurol; 2003; 18(3):149-53. PubMed ID: 14703896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression in hepatolenticular degeneration (Wilson's disease).
    Walter G; Lyndon B
    Aust N Z J Psychiatry; 1997 Dec; 31(6):880-2. PubMed ID: 9483264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.